These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 2703387
1. Positive clinical experience with misonidazole in brachytherapy and external radiotherapy. Baillet F, Housset M, Dessard-Diana B, Boisserie G. Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1073-5. PubMed ID: 2703387 [Abstract] [Full Text] [Related]
2. Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial. Leibel S, Bauer M, Wasserman T, Marcial V, Rotman M, Hornback N, Cooper J, Gillespie B, Pakuris E, Conner N. Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):541-9. PubMed ID: 3104249 [Abstract] [Full Text] [Related]
3. A prospective randomised trial of radiation with or without oral and intravesical misonidazole for bladder cancer. Abratt RP, Craighead P, Reddi VB, Sarembock LA. Br J Cancer; 1991 Nov; 64(5):968-70. PubMed ID: 1931628 [Abstract] [Full Text] [Related]
4. Combinations of CCNU, MISO, and fractionated radiotherapy. Siemann DW, Alliet KL. Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1379-82. PubMed ID: 3759559 [Abstract] [Full Text] [Related]
6. A phase III randomized study of misonidazole plus radiation vs. radiation alone for cervix cancer. Chan P, Milosevic M, Fyles A, Carson J, Pintilie M, Rauth M, Thomas G. Radiother Oncol; 2004 Mar; 70(3):295-9. PubMed ID: 15064016 [Abstract] [Full Text] [Related]
7. Radical irradiation and misonidazole in the treatment of T2 grade III and T3 bladder cancer. Abratt RP, Sealy R, Tucker RD, Williams MA, Barnes DR, Johnson MB, Green JA, Cridland JS. Int J Radiat Oncol Biol Phys; 1983 May; 9(5):629-32. PubMed ID: 6853264 [Abstract] [Full Text] [Related]
9. Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix. Overgaard J, Bentzen SM, Kolstad P, Kjoerstad K, Davy M, Bertelsen K, Mäntyla M, Frankendal B, Skryten A, Löftquist I. Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1069-72. PubMed ID: 2649463 [Abstract] [Full Text] [Related]
10. Enhanced tumor responses through therapies combining CCNU, MISO and radiation. Siemann DW, Hill SA. Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451 [Abstract] [Full Text] [Related]
11. Misonidazole combined with hyperfractionation in the management of malignant glioma. Fulton DS, Urtasun RC, Shin KH, Geggie PH, Thomas H, Muller PJ, Moody J, Tanasichuk H, Mielke B, Johnson E. Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1709-12. PubMed ID: 6090367 [Abstract] [Full Text] [Related]
12. FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer. Thureau S, Dubray B, Modzelewski R, Bohn P, Hapdey S, Vincent S, Anger E, Gensanne D, Pirault N, Pierrick G, Vera P. Radiat Oncol; 2018 Oct 23; 13(1):208. PubMed ID: 30352608 [Abstract] [Full Text] [Related]
13. Partial hypoxia as a cause of radioresistance in a human tumor xenograft: its influence illustrated by the sensitizing effect of misonidazole and hyperbaric oxygen. Reynaud-Bougnoux A, Lespinasse F, Malaise EP, Guichard M. Int J Radiat Oncol Biol Phys; 1986 Aug 23; 12(8):1283-6. PubMed ID: 3759547 [Abstract] [Full Text] [Related]
14. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H. Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838 [Abstract] [Full Text] [Related]
15. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study. Nelson DF, Diener-West M, Weinstein AS, Schoenfeld D, Nelson JS, Sause WT, Chang CH, Goodman R, Carabell S. Int J Radiat Oncol Biol Phys; 1986 Oct 01; 12(10):1793-800. PubMed ID: 3531110 [Abstract] [Full Text] [Related]
16. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice. Siemann DW, Maddison K, Wolf K, Hill SA, Keng PC. Cancer Res; 1985 Jan 01; 45(1):198-202. PubMed ID: 3965132 [Abstract] [Full Text] [Related]
17. Interaction of misonidazole, hyperthermia, and irradiation in a C3H mammary carcinoma and its surrounding skin in vivo. Mao HS, Grau C, Overgaard J. Int J Radiat Oncol Biol Phys; 1992 Jan 01; 22(1):115-22. PubMed ID: 1727107 [Abstract] [Full Text] [Related]
18. Therapeutic gain factors for fractionated radiation treatment of spontaneous murine tumors using fast neutrons, photons plus O2(1) or 3 ATA, or photons plus misonidazole. Suit HD, Sedlacek R, Silver G, Hsieh CC, Epp ER, Ngo FQ, Roberts WK, Verhey L. Radiat Res; 1988 Dec 01; 116(3):482-502. PubMed ID: 3205910 [Abstract] [Full Text] [Related]
19. The effect of prolonged high dose misonidazole on tumor response to radiation. McNally NJ, de Ronde J, Hinchliffe M. Int J Radiat Oncol Biol Phys; 1984 Aug 01; 10(8):1281-5. PubMed ID: 6469751 [Abstract] [Full Text] [Related]
20. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. Overgaard J, Hansen HS, Andersen AP, Hjelm-Hansen M, Jørgensen K, Sandberg E, Berthelsen A, Hammer R, Pedersen M. Int J Radiat Oncol Biol Phys; 1989 Apr 01; 16(4):1065-8. PubMed ID: 2649462 [Abstract] [Full Text] [Related] Page: [Next] [New Search]